NCT07393412 Identifying Risk Factors and Predicting Future Health Outcomes for Korean Patients With Heart and Blood Vessel Diseases: A Long-term Follow-up Study
| NCT ID | NCT07393412 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Samsung Medical Center |
| Condition | Cardiovascular Diseases (CVD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 800,000 participants |
| Start Date | 2026-02-02 |
| Primary Completion | 2026-11-27 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 800,000 participants in total. It began in 2026-02-02 with a primary completion date of 2026-11-27.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to establish a comprehensive, long-term clinical registry infrastructure for heart and brain vascular diseases (cardiovascular diseases and stroke) at Samsung Medical Center. In South Korea, these diseases are a leading cause of death, with a rapidly increasing burden due to an aging population and changing lifestyles. Despite this, there is a lack of large-scale, systematic data specifically focused on the long-term clinical course and unique characteristics of Korean patients. The central hypothesis of this study is that the establishment of a standardized registry infrastructure-integrating both retrospective (historical) and prospective (future) data collection-will provide a more accurate and comprehensive understanding of the natural history and risk factors of heart and brain vascular diseases in the Korean population than currently available fragmented data. By combining existing medical records with ongoing patient follow-up, this infrastructure will serve as a critical scientific platform for developing personalized prevention and precision medicine strategies. By building this organized data collection system, the study will: Construct a robust infrastructure to collect uniform, high-quality clinical data, encompassing both past medical history (retrospective) and future clinical progress (prospective) from a large population of Korean patients. Monitor long-term health outcomes and the progression of diseases by tracking patients over many years. Analyze the interaction between various risk factors and patient outcomes to identify population-specific patterns. Create a scalable platform that can integrate advanced technologies, such as multi-omics and digital health tools, for future research. Ultimately, this integrated registry infrastructure is expected to provide the essential scientific evidence needed to optimize clinical guidelines and improve the long-term quality of life for patients with heart and brain vascular diseases in Korea.
Eligibility Criteria
Inclusion Criteria: A patient who visited Samsung Medical Center due to cardiovascular and cerebrovascular disease. Exclusion Criteria: A patient deemed unable to participate in the study based on the judgment of the medical staff.
Frequently Asked Questions
Who can join the NCT07393412 clinical trial?
This trial is open to participants of all sexes, studying Cardiovascular Diseases (CVD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07393412 currently recruiting?
Yes, NCT07393412 is actively recruiting participants. Visit ClinicalTrials.gov or contact Samsung Medical Center to inquire about joining.
Where is the NCT07393412 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT07393412 clinical trial?
NCT07393412 is sponsored by Samsung Medical Center. The trial plans to enroll 800,000 participants.